|
|
|
Volumn 11, Issue 3, 2012, Pages 420-422
|
|
MelaFind is approved by the FDA: Where does it fit in dermatology?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALGORITHM;
BASAL CELL CARCINOMA;
CANCER SCREENING;
COMPUTER ANALYSIS;
COMPUTER ASSISTED TOMOGRAPHY;
CONFOCAL MICROSCOPY;
COST EFFECTIVENESS ANALYSIS;
DECISION MAKING;
DERMATOLOGIST;
DIAGNOSTIC ACCURACY;
DIGITAL IMAGING;
DRUG APPROVAL;
DRUG MARKETING;
DYSPLASTIC NEVUS;
EPIDERMIS;
EPILUMINESCENCE MICROSCOPY;
FOOD AND DRUG ADMINISTRATION;
GENERAL PRACTITIONER;
HUMAN;
IMAGE RECONSTRUCTION;
LOW ENERGY RADIATION;
MELANOMA;
MULTICENTER STUDY (TOPIC);
NOTE;
PHOTOTHERAPY;
PHYSICIAN;
PROSPECTIVE STUDY;
SENSITIVITY AND SPECIFICITY;
SKIN BIOPSY;
SKIN PIGMENTATION;
WHOLE BODY IMAGING;
DERMATOLOGY;
EUROPEAN UNION;
HUMANS;
IMAGE INTERPRETATION, COMPUTER-ASSISTED;
MELANOMA;
SKIN NEOPLASMS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84858629485
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (8)
|
|
References (4)
|
